← Back to Clinical Trials
Recruiting NCT04998227
Latent TGF-β-binding Proteins Affect the Fibrotic Process in Renal Impairment and Cardiac Dysfunction
Trial Parameters
Condition Acute Coronary Syndrome
Sponsor National Taiwan University Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age 20 Years
Max Age 80 Years
Start Date 2021-04-26
Completion 2025-03-01
Brief Summary
The project is planed to explore the impact of LTBP4 and other matrix protein and potentially related biomarkers on renal outcomes, cardiac outcomes and all-cause mortality in patients with suspected acute coronary syndrome (ACS).
Eligibility Criteria
Inclusion Criteria: \- acute coronary syndrome patients Exclusion Criteria: \- cardiogenic shock, pregnancy, end-stage renal disease